Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
---|
06/22/2005 | CN1207008C Acne ointment and its preparing process |
06/22/2005 | CN1206999C Spreader cong. compound Triamcinolone acetate, and its prepn. method |
06/22/2005 | CN1206984C Pellets having a core coated with an antifungal and a polymer |
06/22/2005 | CN1206980C Shellfish skin care cosmetics |
06/22/2005 | CN1206979C Face-beautifying and spot-removing cream and its preparing process |
06/22/2005 | CN1206976C Compositions and method for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins |
06/22/2005 | CN1206963C Injection for eliminating wrinkles and scar and its prepn |
06/21/2005 | US6909007 Steroidal pharmaceutical compounds |
06/21/2005 | US6908941 Hair and nail treatments using alkanolamines |
06/21/2005 | US6908938 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
06/21/2005 | US6908925 Administering to a candidate subject in need of such treatment, a thus-effective amount of at least one inhibitor of at least one calcium channel for loosening/slackening and/or relaxing cutaneous and/or subcutaneous human skin |
06/21/2005 | US6908920 Pyrimidine derivatives |
06/21/2005 | US6908917 Chromone derivatives as matrix metalloproteinase inhibitors |
06/21/2005 | US6908912 For controlling free-living microorganisms/biofilm growth |
06/21/2005 | US6908889 For shampoos/bath/shower gels for skin/nails/hair comprised of water soluble silicone |
06/21/2005 | US6908616 Composition suitable for immunizing crustaceans by injection against White Spot Syndrome Virus, WSSV, comprising isolated protein consisting of specified amino acid sequence, which delays mortality against WSSV infectivity in crustaceans |
06/21/2005 | CA2309474C New 4-arylpiperidine derivatives for the treatment of pruritus |
06/21/2005 | CA2309473C New 4-arylpiperidine derivatives for the treatment of pruritus |
06/17/2005 | CA2479432A1 Thiazole derivatives |
06/16/2005 | WO2005054213A1 Isoxazole derivative having agonistic activity against peroxisome proliferator-activated receptor |
06/16/2005 | WO2005053718A1 Methods and compositions for treating inflammatory and dermatological conditions |
06/16/2005 | WO2005053680A1 Combination of 2,3-dibenzylbutyrolactone and licochalcone-a |
06/16/2005 | WO2005034883A3 A method of healing skin wounds in mammals and a composition therefor |
06/16/2005 | WO2004071400A3 Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity |
06/16/2005 | WO2004060314A3 Treatment of skin wounds using polyenylphosphatidylcholine and alkanolamines |
06/16/2005 | WO1991001624A8 Use of calcium antagonists for treating scars |
06/16/2005 | US20050132428 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
06/16/2005 | US20050131236 Central nervous ystem disorders; neurodegenerative disorders; muscle contraction; endocrine diseases |
06/16/2005 | US20050131061 Angiogenesis inhibitors |
06/16/2005 | US20050131047 cardiovascular disorders |
06/16/2005 | US20050131035 Medicaments |
06/16/2005 | US20050131024 Antiinflammatory agents; autoimmune diseases; anticancer agents |
06/16/2005 | US20050131005 4-azasteroid derivatives as androgen receptor modulators |
06/16/2005 | US20050131000 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with cdk inhibitory activity |
06/16/2005 | US20050130998 Central nervous ystem diorders; Alzheimer's disease ; anticancer agents |
06/16/2005 | US20050130996 5-(4-{3-chloro-4-(3-fluorobenzyloxy)-anilino}-6-quinazolinyl)-furan-2-carbaldehyde; selective inhibition of the protein tyrosine kinase activity, minimising side effects |
06/16/2005 | US20050130981 Compounds |
06/16/2005 | US20050130967 3-Substituted-4-pyrimidone derivatives |
06/16/2005 | US20050130965 Inhibitors of p38 kinase |
06/16/2005 | US20050130964 e.g 8-oxa-1-thia-benzo[e]naphtho[3,2-h]azulene-2-carboxylic acid ethyl ester; rheumatoid arthritis |
06/16/2005 | US20050130942 (E)-2,4,6-trimethoxystyryl-4-methoxy-3-aminobenzylsulfone for example; cancer, tumors, multiple sclerosis, Pagets disease; antibody conjugates; target receptor tyrosine kinases and which arrest the Ras/Raf/MEK/ERK kinase cascade |
06/16/2005 | US20050130940 Fungal infections; water soluble phosphate derivatives of triazole drugs such as fluconazole |
06/16/2005 | US20050130935 Combination of a beta-2-adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders |
06/16/2005 | US20050130903 Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
06/16/2005 | US20050130902 Upregulate expression of a gene encoding an antioxidative anzyme, such as superoxide dismutase or catalase; neurodegenerative, cardiovascular, cerebral, disorders, trauma, injuries, burns, cancer |
06/16/2005 | US20050130881 Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals |
06/16/2005 | US20050130304 Regulation of endogenous gene expression in cells using zinc finger proteins |
06/16/2005 | US20050130145 polynucleotides which identify and encode human secreted proteins (SECP); expression vectors, host cells, antibodies, and agonists; drug screening |
06/16/2005 | US20050129786 Topical composition having undifferentiated plant seed cells and method for using same |
06/16/2005 | US20050129773 Acne; skin disorders; controlling particle sizes |
06/16/2005 | US20050129747 Crosslinking polyoxyalkylene glycol as oxygen carrier; diabetic tissue degradation |
06/16/2005 | US20050129739 Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsaturated fatty acids from microbes, genetically modified plant seeds and marine organisms |
06/16/2005 | US20050129723 Skin care composition that mediates cell to cell communication |
06/16/2005 | US20050129688 Monkey monoclonal antibodies specific to human B7.1 and/or B7.2 primatized forms thereof, pharmaceutical compositions containing, and use thereof as immunosuppressants |
06/16/2005 | US20050129663 Cellular therapy; for promoting axonal regeneration in the CNS, wound healing and treatment of myocardial infarction and spinal cord injury |
06/16/2005 | US20050129625 Aerosolizing dry powder of interleukin-4 receptor with carbohydrage, lipid, buffer, peptide, protein, Group II metal, or oligopeptide excipient; small aerodynamic particle size; dispersion into gas stream to make inhalant |
06/16/2005 | US20050129618 Screening method for active ingredients; contacting stem cell factor SCF-expressing cells with test ingredients, assaying the amount of SCF produced |
06/16/2005 | CA2588874A1 Composition comprising urginea maritima or drimia maritima, laurus nobilis, adiantum capillus-veneris, and persea americana and its use against hair greasiness, hair loss and for promoting hair growth |
06/16/2005 | CA2547887A1 Protein modifier production inhibitor |
06/16/2005 | CA2546959A1 Composition of herbal extracts for the treatment of atopic dermatitis, skin allergic conditions and acne |
06/16/2005 | CA2545140A1 Use of ppar activators in cosmetics and dermatology |
06/15/2005 | EP1541673A1 Novel probiotics for pet food applications |
06/15/2005 | EP1541634A1 Process for the preparation of micronised collagen, and its therapeutic applications |
06/15/2005 | EP1541580A1 Sulfotransferase inhibitors |
06/15/2005 | EP1541576A1 Furoisoquinoline derivative and use thereof |
06/15/2005 | EP1541574A1 Triazaspiro 5.5 undecane derivatives and drugs comprisi ng the same as the active ingredient |
06/15/2005 | EP1541573A1 Novel crystals of triazaspiro 5.5 undecane derivative |
06/15/2005 | EP1541571A1 Bicyclic unsaturated tertiary amine compound |
06/15/2005 | EP1541570A1 Novel physiologically active substance |
06/15/2005 | EP1541563A1 Ccr4 antagonist and medicinal use thereof |
06/15/2005 | EP1541562A1 Novel uracil derivatives and medicinal use thereof |
06/15/2005 | EP1541174A1 Drug or cosmetic |
06/15/2005 | EP1541163A1 Hair growth stimulants for oral use |
06/15/2005 | EP1541162A1 Intravaginal washing agent |
06/15/2005 | EP1541155A1 Carbon dioxide external preparation and material for formation of carbon dioxide external preparation |
06/15/2005 | EP1541152A1 Combination of a phytosterol and/or cholesterol and licochalcone A or an aqueous extract of Glyzyrrhizae inflata radix comprising licochalcone A |
06/15/2005 | EP1541128A2 Cosmetic composition containing derivatives of cinnamic acid and its use |
06/15/2005 | EP1541126A1 Cosmetic and dermatological composition comprising a combination of a green colouring agent and an antiinflammatory agent |
06/15/2005 | EP1541125A1 Spreadable compositions for topical use, a process of making same and uses thereof |
06/15/2005 | EP1539933A2 Methods of organ regeneration |
06/15/2005 | EP1539927A1 Probiotic bacterium: lactobacillus fermentum |
06/15/2005 | EP1539769A1 Bicyclic heteroaromatic compounds as kinase inhibitors |
06/15/2005 | EP1539766A1 Calcitonin gene related peptide receptor antagonists |
06/15/2005 | EP1539763A1 Azaindole kinase inhibitors |
06/15/2005 | EP1539748A1 2-phenylpyridin-4-yl derivatives as alk5 inhibitors |
06/15/2005 | EP1539741A1 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
06/15/2005 | EP1539739A1 Piperidinyl compounds that selectively bind integrins |
06/15/2005 | EP1539732A1 Novel compounds |
06/15/2005 | EP1539729A2 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
06/15/2005 | EP1539707A1 Method and compounds for promoting healing and reducing inflammation |
06/15/2005 | EP1539701A1 Caspase inhibitors and uses thereof |
06/15/2005 | EP1539696A2 Process for preparing quinolin antibiotic intermediates |
06/15/2005 | EP1539695A1 N-4-piperidinyl compounds as ccr5 modulators |
06/15/2005 | EP1539693A1 Cannabinoid receptor agonists |
06/15/2005 | EP1539692A1 Furanone derivatives and methods of making same |
06/15/2005 | EP1539683A2 Phenol derivatives and their use as rotamase inhibitors |
06/15/2005 | EP1539679A2 Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxigenase-2 selective inhibitors, compositions and methods of use |
06/15/2005 | EP1539678A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc-chemokine receptor ligands |
06/15/2005 | EP1539674A1 Amino-propanol derivatives |
06/15/2005 | EP1539662A1 Cannabinoid receptor ligands |